SEC Form 4 · accession 0001225208-17-018771
Merck & Co., Inc. · MRK
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Adam H Schechter
Officer — EVP & Pres-Global Human Health
Period of report
Dec 15, 2017
Accepted (ET)
Dec 18, 2017 · 1:56 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0000310158
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF1 | Dec 15, 2017 | G | 750 | $0.00 | D | 113,374 | I | By Trust |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1Holdings include shares acquired in dividend reinvestment transactions.